Molecular biologist Florian Wurm, Ph.D., co-founded ExcellGene in 2001 to improve large-scale mammalian cell manufacturing processes. While working for 10 years at Genentech, Hoechst, and academic ...
Hoping to speed up scaleup through detailed modeling of bioreactors, SimVantage, which was founded in December 2021, is working with pharmaceutical companies to help them scale up their bioreactors ...
Lotte Biologics is deploying virtual simulation technology to reduce uncertainty in biopharmaceutical scale-up — widely ...
In a recent effort to scale up the manufacturing of platelets using iPS cell-derived megakaryocytes, Professor Koji Eto (Department of Clinical Application) and his team of researchers, through ...
Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...
Following $8.8m seed round, Biosphere aims to slash biomanufacturing's capital costs by more than 50% OAKLAND, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Biosphere, a startup developing advanced ...
Representative results of turbulent energy and shear stress for VerMES3, VerMES10, and VerMES50. There exists a defective flow space in the area surrounded by yellow dotted lines. iPS cell-derived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results